A new editorial paper was published in Oncotarget titled "Unveiling the non-canonical functions of EZH2 in prostate cancer." Prostate cancer (PCa) is ranked as the second leading cause of ...

CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...

Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function. Researchers have found that the use of the NeuroSAFE technique to guide ...

Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...

Suffering from prostate cancer or benign prostatic hyperplasia (BPH) is not the end of a relationship. Technology and sexologists offer solutions to maintain erections and orgasms, even if ejaculation ...

Focal therapy is a treatment option for prostate cancer. It aims to remove the cancer from the prostate while preserving the rest of the gland. Prostate cancer occurs when cells in the prostate gland ...

Treatment options for prostate cancer have dramatically expanded. Facing a prostate cancer diagnosis often raises concerns among men and their partners: will treatment affect intimacy and their ...

A technique to improve the precision of prostate cancer surgery means that almost twice as many men preserve their erectile function compared to those undergoing standard surgery, according to results ...